AQST Q4 2018 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$427M

Q4 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$17M+38.0% YoY

Gross Profit

$12M71.5% margin

Operating Income

-$12M-73.4% margin

Net Income

-$14M-82.9% margin

EPS (Diluted)

$-0.56

QoQ Revenue Growth

+26.8%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$87M

Total Liabilities

$77M

Stockholders' Equity

$10M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$12M	+38.0%
Gross Profit	$12M	$7M	+82.9%
Operating Income	-$12M	-$7M	-70.2%
Net Income	-$14M	-$10M	-38.9%

Revenue Segments

Manufacture and Supply Revenue

$8M49%

License and Royalty Revenue

$7M44%

Co-Development and Research Fees

$1M7%

Geographic Segments

United States

$16M100%